Preventing opportunistic infections in human immunodeficiency virus-infected persons: Implications for the developing world

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 1, 1996, Pages 1-11

  Kaplan, Jonathan E ^a   Hu, Dale J ^a   Holmes, King K ^b   Jaffe, Harold W ^c   Masur, Henry ^d   De Cock, Kevin M ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS CARINII; STREPTOCOCCUS PNEUMONIAE;

COTRIMOXAZOLE; FLUCONAZOLE; ISONIAZID; PNEUMOCOCCUS VACCINE;

AIDS RELATED COMPLEX; BACTERIAL INFECTION; CRYPTOCOCCOSIS; DEVELOPING COUNTRY; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOBAR PNEUMONIA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; REVIEW; TOXOPLASMOSIS; TROPICAL DISEASE; TUBERCULOSIS;

ANTIBIOTICS; BACTERIAL AND FUNGAL DISEASES; DEVELOPING COUNTRIES; DISEASES; DRUGS; HIV INFECTIONS--COMPLICATIONS; INFECTIONS; LITERATURE REVIEW; MULTIREGIONAL ANALYSIS; RESEARCH METHODOLOGY; TREATMENT; TUBERCULOSIS; VACCINES; VIRAL DISEASES;

AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; ASIA; BACTERIAL VACCINES; CARIBBEAN REGION; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; HUMANS; ISONIAZID; LATIN AMERICA; PNEUMOCOCCAL VACCINES; RESEARCH; SULFAMETHOXAZOLE; TRIMETHOPRIM;

EID: 0029680239     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.1.tm0550010001     Document Type: Article

References (113)

1. Anonymous, 1995. The current global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec 70: 195-196.
2. Kaplan JE, Masur H, Holmes KK, McNeil MM, Schonberger LB, Navin TR, Hanson DL, Gross PA, Jaffe HW, USPHS/IDSA Prevention of Opportunistic Infections Working Group, 1995. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. Clin Infect Dis 21 (suppl 1): S1-S11.
3. Kaplan JE, Masur H, Holmes KK, Wilfert CM, Sperling R, Baker SA, Trapnell CB, Freedberg KA, Cotton D, Powderly WG, Jaffe HW, USPHS/IDSA Prevention of Opportunistic Infections Working Group, 1995. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clin Infect Dis 21 (suppl 1): S12-S31.
4. USPHS/IDSA Prevention of Opportunistic Infections Working Group, 1995. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. Clin Infect Dis 21 (suppl 1): S32-S43.
5. Mulder DW, Nunn AJ, Wagner HU, Kamali A, Kengeya-Kayondo JF. 1994. HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort. AIDS 8: 87-92.
6. Greenberg AE, Nsa W, Ryder RW, Medi M, Nzeza M, Kitadi N, Baangi M, Malanda N, Davachi F, Hassig SE, 1991. Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. N Engl J Med 325: 105-109.
7. Nguyen-Dinh P, Greenberg AE, Mann JM, Kabote N, Francis H, Colebunders RL, Huong AY, Quinn TC, Davachi F, Lyamba B, Kalemba K, Embonga B, 1987. Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire. Bull World Health Organ 65: 607-613.
8. Pepin J, Ethier L, Kazadi C, Milord F, Ryder R, 1992. The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire. Am J Trop Med Hyg 47: 133-140.
9. Meda HA, Doua F, Laveissiere C, Miezan TW, Gaens E, Brattegaard K, deMuynck A, De Cock KM, 1995. Human immunodeficiency virus infection and human African trypanosomiasis: a case control study in Cote d'Ivoire. Trans R Soc Trop Med Hyg 89: 639-643.
10. Steketee RW, Wirima JJ, Bloland PB, Chelima B, Mermin JH, Chitsulo L, Breman JG, 1996. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55: (suppl): (in press).
11. Wallis RS, Vjecha M, Amir-Tabmasseb M, Okwera A, Byekwaso F, Nyole S, Kabengera S, Mugerwa RD, Ellner JJ, 1993. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 167: 43-48.
12. Whalen C, Horsburgh CR, Horn D, Lahart C, Simberkoff M, Ellner J, 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 151: 129-135.
13. Cooper DA, Pehrson PO, Pedersen C, Moroni M, Oksenhendler E, Rozenbaum W, Clumeck N, Faber V, Stille W, Hirschel B, Farthing C, Doherty R, Yeo JM, and a European-Australian Collaborative Group, 1993. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. AIDS 7: 197-207.
14. Youle MS, Gazzard BG, Johnson MA, Cooper DA, Hoy JF, Busch H, Ruf B, Griffiths PD, Stephenson SL, Dancox M, Bell AR, 1994. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. AIDS 8: 641-649.
15. Gilks CF, Brindle RJ, Otieno LS, Simani PM, Newnham RS, Bhatt SM, Lule GN, Okelo GB, Watkins WM, Waiyaki PG, Were JBO, Warrell DA, 1990. Life-threatening, bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 336: 545-549.
16. Vugia DJ, Kiehlbauch JA, Yeboue K, N'Gbichi JM, Lacina D, Maran M, Gondo M, Kouadio K, Kadio A, Lucas SB, Kestens L, Crawford JT, Wells JG, Brattegaard K, De Cock KM, Griffin PM, 1993. Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, west Africa. J Infect Dis 168: 564-570.
17. Nelson AM, Perriens JH, Kapita B, Okonda L, Lusamuno N, Kalengayi MR, Angritt P, Quinn TC, Mullick FG, 1993. A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaire: is passive surveillance valid? AIDS 7: 1241-1245.
18. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C, Doorly R, Brattegaard K, Kestens L, Smithwick R, Kadio A, Ezani N, Yapi A, De Cock KM, 1993. The mortality and pathology of HIV infection in a west African city. AIDS 7: 1569-1579.
19. Abouya YL, Beaumel A, Lucas S, Dago-Akribi A, Coulibaly G, N'Dhatz M, Konan JB, Yapi A, De Cock KM, 1992. Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 145: 617-620.
20. Pallangyo K, Hakanson A, Lema L, Arris E, Mteza I, Palsson K, Yangi E, Mhalu F, Biberfeld G. Britton S, 1992. High HTV seroprevalence and increased HIV-associated mortality among hospitalized patients with deep bacterial infections in Dar es Salaam, Tanzania. AIDS 6: 971-976.
21. Gilks CF, Otieno LS, Brindle RJ, Newnham RS, Lule GN, Were JB, Simani PM, Bhatt SM, Okelo GB, Waiyaki PG, Warrell DA, 1992. The presentation and outcome of HIV-related disease in Nairobi. Q J Med 82: 25-32.
22. Colebunders R, Francis H, Mann JM, Bila KM, Izaley L, Kimputu L, Behets F, Van der Groen G, Quinn TC, Curran JW, Piot P, 1987. Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol 82: 859-864.
23. Conlon CP, Pinching AJ, Perera CU, Moody A, Luo NP, Lucas SB, 1990. HIV-related enteropathy in Zambia: a clinical, microbiological, and histological study. Am J Trop Med Hyg 42: 83-88.
24. Sewankambo N, Mugerwa RD, Goodgame R, Carswell JW, Moody A, Lloyd G, Lucas SB, 1987. Enteropathic AIDS in Uganda. An endoscopic, histological and microbiological study. AIDS 1: 9-13.
25. Drobniewski F, Kelly P, Carew A, Ngwenya B, Luo N, Pankhurst C, Farthing M, 1995. Human microsporidiosis in African AIDS patients with chronic diarrhea (letter). J infect Dis 171: 515-516.
26. Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Honde M, Beaumel A, Kestens L, Kadio A, 1994. Contribution of tuberculosis to slim disease in Africa. Br Med J 308: 1531-1533.
27. Kamanfu G, Mlika-Cabanne N, Girard PM, Nimubona S, Mpfizi B, Cishako A, Roux P, Coulaud JP, Larouze B, Aubry P, Murray JF, 1993. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis 147: 658-663.
28. Anonymous, 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41: 1-19.
29. Gilks CF, Brindle RJ, Mwachari C, Batchelor B, Bwayo J, Kimari J, Arbeit RD, von Reyn CF, 1995. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol 8: 195-198.
30. Malin AS, Gwanzuta LK, Klein S, Robertson VJ, Musvaire P, Mason PR, 1995. Pneumocystis carinii pneumonia in Zimbabwe. Lancet 346: 1258-1261.
31. Lucas SB, Peacock CS, Hounnou A, Brattegaard K, Koffi K, Honde M, Andoh J, Bell J, De Cock KM, 1996. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. Br Med J 312: 335-338.
32. Okello DO, Sewankambo N, Goodgame R, Aisu TO, Kwezi M, Mottissey A, Ellner JJ, 1990. Absence of bacteremia with Mycobacterium avium-tntracellulare in Ugandan patients with AIDS. J Infect Dis 162: 208-210.
33. Ziegler JL, 1993. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 342: 1348-1351.
34. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS, 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
35. Moore PS, Chang Y, 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332: 1181-1185.
36. Mukadi Y, Perriens JH, St. Louis ME, Brown C, Prignot J, Willame JC, Pouthier F, Kaboto M, Ryder RW, Portaels F, Piot P, 1993. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 342: 143-146.
37. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, Greenberg AE, De Cock KM, 1995. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 345: 607-610.
38. Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, van Niekerk AR, Becker D, Weilbach CN, Iwanik J, Keddy K, Miller GB, Ozbay B, Ryan A, Viscovic T, Woolf M, 1995. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 8: 386-391.
39. Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, Batchelor BIF, Kimari JN, Newnham R, Bwayo J, Plummer FA, Warrell DA, 1996. Invasive pneumococcal disease in a cohort of predominantely HIV-1 infected female sex workers in Nairobi, Kenya. Lancet 347: 718-723.
40. Murillo J, Castro KG, 1994. HIV infection and AIDS in Latin America. Epidemiologic features and clinical manifestations. Infect Dis Clin North Am 8: 1-11.
41. Volkow P, Ponce de Leon S, Calva J, Ruiz-Palacios G, Mohar A, 1993. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival. Rev Invest Clin 45: 133-138.
42. Mohar A, Romo J, Salido F, Jessurun J, Ponce de Leon S, Reyes E, Volkow P, Larraza O, Peredo MA, Cano C, Gomez G, Sepulveda J, Mueller N, 1992. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 6: 467-473.
43. Jessurun J, Angeles-Angeles A, Gasman N, 1990. Comparative demographic and autopsy findings in acquired immune deficiency syndrome in two Mexican populations. J Acquir Immune Defic Syndr 3: 579-583.
44. Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, Beckstead JH, 1984. Autopsy findings in the acquired immune deficiency syndrome. JAMA 252: 1152-1159.
45. d'Arminio Monforte A, Vago L, Lazzarin A, Boldorini R, Bini T, Guzzetti S, Antinori S, Moroni M, Costanzi G, 1992. AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS 6: 1159-1164.
46. Zacarias F, Gonzalez RS, Cuchi P, Yanez A, Peruga A, Mazin R, Betts C, Weissenbacher M, 1994. HIV/AIDS and its interaction with tuberculosis in Latin Amenca and the Caribbean. Bull Pan Am Health Organ 28: 312-323.
47. Garcia Garcia ML, Valdespino Gomez JL, Garcia Sancho MC, Salcedo Alvarez RA, Zacarias F, Sepulveda Amor J, 1995. Epidemiology of AIDS and tuberculosis. Bull Pan Am Health Organ 29: 37-58.
48. Slutsker L, Castro KG, Ward JW, Dooley SW Jr, 1993. Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. Clin Infect Dis 16: 513-518.
49. Braun MM, Byers RH, Heyward WL, Ciesielski CA, Bloch AB, Berkelman RL, Snider DE, 1990. Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 150: 1913-1916.
50. Hu DJ, Fleming PL, Castro KG, Jones JL, Bush TJ, Hanson D, Chu SY, Kaplan J, Ward JW, 1995. How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions?. J Acquir Immune Defic Syndr Hum Retrovirol 10: 374-380.
51. Guizelini E, Amato Neto V, 1992. Isolation of oocysts of Cryptosporidium sp. in loose stools of patients with AIDS and of immunocompetent children and adults in Sao Paulo, Brazil. Rev Hosp Clin Fac Med Sao Paulo 47: 150-152.
52. Rodrigues JL, Leser P, Silva T do M, dos Santos MI, Dalboni MA, Acceturi CA, Castelo Filho A, 1991. Prevalence of cryptosporidiosis in diarrheic syndrome in HIV positive patients. Rev Assoc Med Bras 37: 79-84.
53. Sanchez-Mejorada G, Ponce-de-Leon S, 1994. Clinical patterns of diarrhea in AIDS: etiology and prognosis. Rev Invest Clin 46: 187-196.
54. Romo Garcia J, Salido Rengell F, Jessurum J, Dieguez M, Vick Fragoso R, Higuera Ramirez F, 1991. Causes and factors of diarrhea in the acquired immunodeficiency syndrome in a hospital of Mexico City. Rev Clin Esp 189: 218-220.
55. Wuhib T, Silva TM, Newman RD, Garcia LS, Pereira ML, Chaves CS, Wahlquist SP, Bryan RT, Guerrant RL, Sousa A de Q, de Queiroz TRBS, Sears CL, 1994. Cryptosporidial and microsporidial infections in human immunodeficiency virus-infected patients in northeastern Brazil. J Infect Dis 170: 494-497.
56. Richards FO Jr, Kovacs JA, Luft BJ, 1995. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis 21 (suppl 1): S49-S56.
57. Luft BJ, Remington JS, 1992. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15: 211-222.
58. Lucas SB, 1990. Missing infections in AIDS. Trans R Soc Trop Med Hyg 84 (suppl 1): 34-38.
59. DeHovitz JA, Pape JW, Boncy M, Johnson WD Jr, 1986. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 315: 87-90.
60. Moura H, Fernandes O, Viola JP, Silva SP, Passos RH, Lima DB, 1989. Enteric parasites and HIV infection: occurrence in AIDS patients in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 84: 527-533.
61. Kreiss JK, Castro KG, 1990. Special considerations for managing suspected human immunodeficiency virus infection and AIDS in patients from developing countries. J Infect Dis 162: 955-960.
62. de Campos EP, Carvalho VO, Marinho SF, Kushnaroff TM, Galvao PA, Padovani CR, 1992. A retrospective therapeutic study of neurocryptococcosis in 112 AIDS and non-AIDS patients. Rev Soc Bras Med Trop 25: 241-246.
63. Barreto JA, Palaci M, Ferrazoli L, Martins MC, Suleiman J, Lorenco R, Ferreira OC Jr, Riley LW, Johnson WD Jr, Galvao PA, 1993. Isolation of Mycobacterium avium complex from bone marrow aspirates of AIDS patients in Brazil. J Infect Dis 168: 777-779.
64. Del Castillo M, Mendoza G, Oviedo J, Perez Bianco RP, Anselmo AE, Silva M, 1990. AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med 88: 693-694.
65. Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Junior G, Metz K, Lopes ER, 1994. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261-268.
66. Oddo D, Casanova M, Acuna G, Ballesteros J, Morales B, 1992. Acute Chagas' disease (Trypanosomiasis americana) in acquired immunodeficiency syndrome: report of two cases. Hum Pathol 23: 41-44.
67. Da-Cruz AM, Machado ES, Menezes JA, Rutowitsch MS, Coutinho SG, 1992. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg 86: 511-512.
68. Hernandez D, Rodriguez N, Martinez C, Garcia L, Convit J, 1993. Leishmania braziliensis causing visceral leishmaniasis in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg 87: 627-628.
69. Montalban C, Calleja JL, Erice A, Laguna F, Clotet B, Podzamczer D, Cobo J, Mallolas J, Yebra M, Gallego A, 1990. Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect 21: 261-270.
70. Schainberg L, Scheinberg MA, 1989. Recovery of Strongyloides stercoralis by bronchoalveolar lavage in a patient with acquired immunodeficiency syndrome. Am J Med 87: 486.
71. Goldani LZ, Sugar AM, 1995. Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis 21: 1275-1281.
72. Schlesinger I, Oelrich DM, Tyring SK, 1994. Crusted (Norwegian) scabies in patients with AIDS: the range of clinical presentations. South Med J 87: 352-356.
73. Jain MK, John TJ, Keusch GT, 1994. A review of human immunodeficiency virus infection in India. J Acquir Immune Defic Syndr 7: 1185-1194.
74. Kaur A, Babu PG, Jacob M, Narasimhan C, Ganesh A, Saraswathi NK, Mathai D, Pulimood BM, John TJ, 1992. Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr 5: 883-889.
75. Tripathy SP, 1991. Tuberculosis and AIDS. Indian J Tubercul 38: 49-50.
76. Swasdisevi A, 1994. Clinical study of HIV disease in the lower area of northern Thailand in 1994. J Med Assoc Thai 77: 440-443.
77. Singh YN, Singh S, Rattan A, Ray JC, Sriniwas TR, Kumar A, Khare SD, Wali JP, Malaviya AN, 1993. Pneumocystis carinii infection in patients of AIDS in India. J Assoc Physicians India 41: 41-42.
78. Singh YN, 1994. PCP among AIDS patients in India. J Acquir Immune Defic Syndr 7: 872-873.
79. Eng P, Chew SK, Chan KW, Monteiro E, 1991. HIV infection and Pneumocystis carinii pneumonia-bronchoscopic diagnosis in two patients. Ann Acad Med Singapore 20: 396-398.
80. Joshi SR, Parmar DV, Deshpande AK, 1994. Herpes simplex encephalitis in HIV-1 infection and AIDS in India. J Assoc Physicians India 42: 264.
81. Panda S, Sarkar S, Mandal BK, Singh TB, Singh KL, Mitra DK, Sarkar K, Tripathy SP, Deb BC, 1994. Epidemic of herpes zoster following an HIV epidemic in Manipur, India. J Infect 28: 167-173.
82. Thongcharoen P, Vitayasai P, Vithayasai V, Supparatpinyo K, Tansuphaswasdikul S, 1992. Opportunistic infections in AIDS/HIV infected patients in Thailand. Thai AIDS J 4: 117-122.
83. Imwidthaya P, 1994. Systemic fungal infections in Thailand. J Med Vet Mycol 32: 395-399.
84. Imwidthaya P, 1994. One year's experience with Cryptococcus neoformans in Thailand. Trans R Soc Trop Med Hyg 88: 208.
85. Chiewchanvit S, Chuaychoo B, Mahanupab P, 1994. Disseminated cryptococcosis presenting as molluscum-like lesions in three male patients with acquired immunodeficiency syndrome. J Med Assoc Thai 77: 322-326.
86. Li PCK, Yeoh EK, 1989. AIDS in Hong Kong: the first twenty two cases. J Hong Kong Med Assoc 41: 152-155.
87. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T, 1994. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 344: 110-113.
88. Imwidthaya P, 1994. Update of Penicillosis marneffei in Thailand. Review article. Mycopathologia 127: 135-137.
89. Peto TE, Bull R, Millard PR, Mackenzie DW, Campbell CK, Haines ME, Mitchell RG, 1988. Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus. J Infect 16: 285-290.
90. Deng Z, Ribas JL, Gibson DW, Connor DH, 1988. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 10: 640-652.
91. Sathapatayavongs B, Damrongkitchaipom S, Saengditha P, Kiatboonsri S, Jayanetra P, 1989. Disseminated penicilliosis associated with HIV infection. J Infect 19: 84-85.
92. Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T, 1992. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis 14: 871-874.
93. Li PC, Tsui MC, Ma KF, 1992. Penicillium marneffei: indicator disease for AIDS in South East Asia. AIDS 6: 240-241.
94. Viviani MA, Tortorano AM, Rizzardini G, Quirino T, Kaufman L, Padhye AA, Ajello L, 1993. Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur J Epidemiol 9: 79-85.
95. Kronauer CM, Schar G, Barben M, Buhler H, 1993. HIV-associated Penicillium marneffei infection. Schweiz Med Wochenschr 123: 385-390.
96. Fischl MA, Dickinson GM, La Voie L, 1988. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 259: 1185-1189.
97. Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, vander Graaf Y, Frissen JP, van der Ende IM, Kolsters AF, Borleffs JC, 1992. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 327: 1836-1841.
98. Mallolas J, Zamora L, Gatell JM, Miro JM, Vernet E, Valls ME, Soriano E, San Miguel JG, 1993. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS 7: 59-64.
99. Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J, 1995. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 332: 693-699.
100. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ, Powderly WG, Steigbigel PT, Zuger A, Holzman RS, 1992. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 327: 1842-1848.
101. Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, Kassim S, Ackah A, De Cock KM, 1995. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. AIDS 9: 1251-1254.
102. Landay A, Ho JL, Hom D, Russell T, Zwerner R, Minuty JG, Kataaha P, Mmiro F, Jackson B, 1993. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS 7: 1565-1568.
103. Anonymous, 1993. Proposed 'World Health Organization staging system for HIV infection and disease': preliminary testing by an international collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS 7: 711-718.
104. Montaner JS, Le TN, Le N, Craib KJ, Schechter MT, 1992. Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS 6: 719-724.
105. Vandenbruaene M, Colebunders R, Goeman J, Alary M, Farber CM, Kestens L, van Ham G, Van den Ende J, Van Gompel A, Van den Enden E, Soete F, 1993. Evaluation of two staging systems for HIV infection for use in developing countries. AIDS 7: 1613-1615.
106. Schechter M, Zajdenverg R, Machado L, Pinto ME, Lima LA, Perez MA, 1994. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J Acquir Immune Defic Syndr 7: 163-168.
107. Lifson AR, Allen S, Wolf W, Serufilira A, Kantarama G, Lindan C, Hudes ES, Nsengumuremyi F, Taelman H, Batungwanayo J, 1995. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 122: 262-270.
108. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr, 1993. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342: 268-272.
109. Anonymous, 1993. Tuberculosis preventive therapy in HIV-infected individuals. A Joint Statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD). Wkly Epidemiol Rec 68: 361-364.
110. De Cock KM, Grant A, Porter JD, 1995. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet 345: 833-836.
111. Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, Hooton TM, Hyslop N, Spector SA, Bozette SA, 1995. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 332: 700-705.
112. O'Brien RJ, Perriens JH, 1995. Preventive therapy for tuberculosis in HIV infection: the promise and the reality. AIDS 9: 665-673.
113. Anonymous, 1991. Guidelines for the Clinical Management of HIV Infection in Adults. December 1991. Geneva: World Health Organization.